Results 51 to 60 of about 1,445,344 (302)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

open access: yesPharmaceuticals, 2022
Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini   +5 more
doaj   +1 more source

A students' perspective of the effect of withdrawal programming in New Zealand primary schools : a thesis presented in partial fulfillment of the requirements for the degree of Masters in Education at Massey University [PDF]

open access: yes, 2006
Gifted and talented students have a voice and their own perceptions of their involvement in programmes aimed at catering for their unique abilities.
Walsh, Corinne Louise
core  

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Uso de metadona para el destete de sedación en paciente pediátrico

open access: yesRevista Electrónica de AnestesiaR, 2019
Los opioides usados  durante más de cinco días, para sedación en paciente pediátrico, deben ser retirado de forma progresiva con el objetivo de prevenir abstinencia.
Rubén Ferreras Vega   +3 more
doaj   +1 more source

From consumption to withdrawal: A broad synopsis of the effects of alcohol

open access: yesMedicine Advances, 2023
The consumption of alcohol reflects both societal norms and personal choices and has major clinical implications. Long‐term excess alcohol consumption leads to a domino effect of pathological outcomes and onset of chronic illness.
Jun Zhu   +6 more
doaj   +1 more source

Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain [PDF]

open access: yes, 2017
Background: L-acetylcarnitine, a drug marketed for the treatment of chronic pain, causes analgesia by epigenetically up-regulating type-2 metabotropic glutamate (mGlu2) receptors in the spinal cord.
Battaglia, Giuseppe   +10 more
core   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

Über die Brunnentiefe eines Rätsels. Anmerkungen zur Frage nach der Tiefe des menschlichen Daseins im Denken Martin Heideggers [PDF]

open access: yesPhainomena
On the Well Depth of an Enigma. Notes on the Question of the Depth of Human Existence in Martin Heidegger’s Thought - Heidegger did not conceive a “theory” of depth, but his ways of thinking may be characterized by his own withdrawal into the ...
Johannes Vorlaufer
doaj   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis

open access: yesActa Dermato-Venereologica, 2022
In clinical practice, interruption of treatment may not result in immediate cessation of disease control, and some patients even experience sustained treatment response following treatment interruption.
Kim Papp   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy